Events calendar

European Respiratory Society Congress 2019

Booth #S08 | IFEMA Feria de Madrid
Madrid, Spain | 28 September to 2 October

0
day days
0
hour hours
0
minute minutes
0
second seconds

Philips connects data, technology and people – seamlessly.

 

Every day, healthcare moves forward. Yet even the most advanced healthcare networks can be more integrated. Systems need to talk to each other. Data needs to be available wherever it’s needed. At Philips, we help create seamless solutions that connect people, technology and data across the care continuum.

 

There’s no limit to what we can do together. Because today health knows no bounds, and neither should healthcare.

See how Philips is removing the boundaries of care

 

We hope you’ll join us at booth #S08 to learn more! Don’t miss our in-booth forum with an exciting program of innovation and clinical updates.


Join us at
our workshops

Sunday, September 29

1.15-2.30 pm | Room N101+102

Expiratory Flow Limitation

 

Chair:

Dr. David White (Denver, USA)

Program

 

  • Physiology of COPD & EFL. Prof. Peter M.A. Calverley (Liverpool, UK)
One hallmark of chronic obstructive pulmonary disease (COPD) is the occurrence of expiratory flow limitation (EFL), which occurs in the lower airways during quiet breathing. In some patients with COPD, EFL is present during tidal breathing. Called tidal EFL, this causes patients to breathe at increased lung volumes (hyperinflation), which leads to dyspnea and can increase the work of breathing when the patient is at rest.

The presence of EFL during a COPD exam could indicate that a patient has more severe physiological conditions, and there is a significant correlation between COPD patients with EFL and worse health status, symptom score and overall disease burden. Identifying EFL and tidal EFL can therefore be incredibly beneficial in improving outcomes for COPD patients, but it can often go undetected in a clinical setting.

 

EFL identification could be highly useful in stratifying patients by the severity of their COPD or treatment responses. COPD patients with EFL are more likely to exacerbate sooner, are hospitalized more often, and have increased mortality rates. The technology is therefore something that could tangibly improve patients' quality of life, and remove burdens on healthcare resources. We’re talking more about it this week at ERS.

Monday, September 30

1.15-2.30 pm | Room N101+102

Central sleep apnea management and use of Artificial Intelligence in sleep stages scoring

 

Chairs:

Dr. David White (Denver, USA)

Prof. Michael Arzt (Regensburg, Germany)

Program

 

  • Central Sleep Apnea Management. Prof. Michael Arzt (Regensburg, Germany)
  • Central sleep apnea - Interactive clinical cases. Dr. Stefania Redolfi (Paris, France)
  • Sleep staging : Inter-scorer agreement modelled by Artificial Intelligence - Interactive scoring session. Peter Anderer (Wien, Austria)

Tuesday, October 1

1.15-2.30 pm | Room N101+102

New Principles in the Continuum of COPD & NIV Management

 

Chairs:

Dr. Teofilo Lee-Chiong (Denver, USA)
Prof. Nicholas Hart (London, UK)

Program

 

  • Reducing hospital readmissions in severe COPD’. Prof. Nicholas Hart (London, UK)
  • E2E management of COPD patients (Interactive cases). Prof. Michael Polkey (London, UK)
  • Role of non-invasive ventilator data in the clinical decision process (Interactive cases). Dr. Swapna Mandal (London, UK)
  • Transitioning to a new life support ventilator – Julie Yarascavitch, Bill Truschel (Pittsburgh, USA)

Join us at our workshops

Sunday, 16 September

Advanced Monitoring for a next generation ventilator

Teofilo Lee-Chiong, MD

Cesare Gregoretti, MD

13:15-14:30

Room 7.3L

Monday, 17 September

Expiratory flow limitation: what it is and why it matters

Dr. Peter Calverle

13:15-14:30

Room 7.3L

Stay connected for Philips news, exclusive updates, and more.

Contact information

* This field is mandatory
*
*
*
*
*
*
*
*
*
By specifying your reason for contact we will be able to provide you with a better service.
*
*